Market Forecast By Product Type (Instruments, Reagents & Kits), By Technology (Molecular Tests, Serology Tests), By End User (Independent Clinical Laboratories, Hospital-based Laboratories, Others) And Competitive Landscape
Product Code: ETC4471842 | Publication Date: Jul 2023 | Updated Date: Aug 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 | |
Report Name | Qatar Blood Screening Market |
Forecast period | 2025-2031 |
CAGR | 9.3% |
Growing Sector | Healthcare |
Qatar Blood Screening Market report thoroughly covers the market By Product Type, By Technology, and By End User. The market outlook report provides an unbiased and detailed analysis of the ongoing market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
Qatar Blood Screening Market is characterized by its growing demand for blood transfusion services and an increasing need for testing for infectious diseases through blood screening. The market size is expected to grow significantly due to government initiatives to improve blood safety and quality.
According to 6Wresearch, the Qatar Blood Screening Market size is anticipated to grow at a CAGR of 9.3% during the forecast period of 2025-2031. The increasing demand for blood transfusion services and a rising population are key factors driving growth in the market. Qatar has a high demand for blood transfusion services, primarily due to the high prevalence of chronic diseases such as cancer and thalassemia. Several trends have been observed in the Qatar blood screening market that are expected to shape its growth trajectory. One notable trend is the growing preference for noninvasive blood screening tests such as molecular and serological tests that are considered safer and less invasive. Despite its growth, the Qatar blood screening market faces significant challenges. One such challenge is the lack of skilled healthcare professionals capable of conducting blood screening tests.
Furthermore, the high cost of blood screening tests and inadequate funding towards healthcare infrastructure are impacting the market growth negatively. The Qatar blood screening market offers several opportunities for growth and development. The increasing adoption of advanced technology and the integration of digital solutions in blood screening processes are expected to enhance the accuracy and speed of test results. Furthermore, the entry of new stakeholders into the market and the establishment of new blood transfusion centers offer opportunities for Qatar Blood Screening Market Growth.
The government of Qatar has introduced several initiatives geared towards strengthening the country's blood screening market. One such program is the National Blood Transfusion Service (NBTS), launched in 2005. The NBTS aims to provide safe, adequate, and timely blood supply to all residents of Qatar. The program operates based on WHO's recommendations and standards, ensuring that all blood donors undergo rigorous screening and testing before blood is supplied to patients.
The Qatar blood screening industry has witnessed a substantial influx of major players, including Grifols, Bio-Rad Laboratories, and Abbott Laboratories. Grifols is a major player in the global diagnostic market and offers blood screening technology that can detect various diseases such as HIV, Hepatitis B and C, and Syphilis, among others.
The Qatar blood screening market is set to experience significant growth in the years to come. Several factors are driving this growth, including an increasing prevalence of infectious diseases like HIV and Hepatitis. Technological advancements in blood screening methods are also expected to enhance the market's performance. The development of next-generation sequencing technology has paved the way for more accurate, rapid, and cost-effective blood screening methods. Additionally, government policies supporting research and innovation in healthcare and growing awareness of the importance of blood screening in disease management are key drivers for the market development.
According to Parth, Senior Research Analyst, 6Wresearch, the market for reagents & kits is expected to grow significantly due to the rising prevalence of infectious diseases and the increasing demand for point-of-care testing.
By Technology, the Qatar blood screening market is segmented into molecular tests and serology tests. Molecular tests are expected to dominate the Qatar Blood Screening Market Share due to their high sensitivity and accuracy in detecting infectious diseases.
The report offers a comprehensive study of the subsequent market segments:
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Qatar Blood Screening Market Overview |
3.1 Qatar Country Macro Economic Indicators |
3.2 Qatar Blood Screening Market Revenues & Volume, 2021 & 2031F |
3.3 Qatar Blood Screening Market - Industry Life Cycle |
3.4 Qatar Blood Screening Market - Porter's Five Forces |
3.5 Qatar Blood Screening Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Qatar Blood Screening Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Qatar Blood Screening Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Qatar Blood Screening Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about blood screening importance in Qatar |
4.2.2 Government initiatives to enhance healthcare infrastructure |
4.2.3 Rising prevalence of chronic diseases requiring regular blood testing |
4.3 Market Restraints |
4.3.1 Limited availability of skilled healthcare professionals for blood screening |
4.3.2 High cost associated with advanced blood screening technologies |
5 Qatar Blood Screening Market Trends |
6 Qatar Blood Screening Market, By Types |
6.1 Qatar Blood Screening Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Qatar Blood Screening Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Qatar Blood Screening Market Revenues & Volume, By Instruments, 2021 - 2031F |
6.1.4 Qatar Blood Screening Market Revenues & Volume, By Reagents & Kits, 2021 - 2031F |
6.2 Qatar Blood Screening Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Qatar Blood Screening Market Revenues & Volume, By Molecular Tests, 2021 - 2031F |
6.2.3 Qatar Blood Screening Market Revenues & Volume, By Serology Tests, 2021 - 2031F |
6.3 Qatar Blood Screening Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Qatar Blood Screening Market Revenues & Volume, By Independent Clinical Laboratories, 2021 - 2031F |
6.3.3 Qatar Blood Screening Market Revenues & Volume, By Hospital-based Laboratories, 2021 - 2031F |
6.3.4 Qatar Blood Screening Market Revenues & Volume, By Others, 2021 - 2031F |
7 Qatar Blood Screening Market Import-Export Trade Statistics |
7.1 Qatar Blood Screening Market Export to Major Countries |
7.2 Qatar Blood Screening Market Imports from Major Countries |
8 Qatar Blood Screening Market Key Performance Indicators |
8.1 Number of blood screening tests conducted annually |
8.2 Percentage of population undergoing regular blood screening |
8.3 Adoption rate of new blood screening technologies |
8.4 Average turnaround time for blood test results |
8.5 Rate of compliance with blood screening guidelines |
9 Qatar Blood Screening Market - Opportunity Assessment |
9.1 Qatar Blood Screening Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Qatar Blood Screening Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Qatar Blood Screening Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Qatar Blood Screening Market - Competitive Landscape |
10.1 Qatar Blood Screening Market Revenue Share, By Companies, 2024 |
10.2 Qatar Blood Screening Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |